Bragar

ANNOVIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Annovis Bio, Inc. on Behalf of Annovis Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, August 4, 2021

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Annovis Bio, Inc. (Annovis or the Company) (NYSEAM: ANVS) on behalf of Annovis stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Annovis Bio, Inc. (Annovis or the Company) (NYSEAM: ANVS) on behalf of Annovis stockholders.
  • Our investigation concerns whether Annovis has violated the federal securities laws and/or engaged in other unlawful business practices.
  • Annovis is a clinical-drug company that develops drugs for the treatment of neurodegenerative diseases.
  • Following this news, Annovis stock price declined $65.94 per share or over 60% to close at $43.50 on July 29, 2021.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Home Point, James River, Kanzhun, and BlueCity and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, July 29, 2021

On May 6, 2021, Home Point Capital issued a press release announcing Home Point Capitals financial results for the first quarter of 2021.

Key Points: 
  • On May 6, 2021, Home Point Capital issued a press release announcing Home Point Capitals financial results for the first quarter of 2021.
  • Among other results, Home Point Capital reported revenue of $324.2 million, missing consensus estimates by $41.72 million.
  • On this news, Home Point Capitals stock price fell nearly 18%, closing at $7.70 per share.
  • For more information on the BlueCity class action go to: https://bespc.com/cases/BLCT
    About Bragar Eagel & Squire, P.C.

WEST SUBURBAN BANCORP ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of WNRP and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, July 27, 2021

On July 26, 2021, West Suburban announced that it had entered into an agreement to merge with Old Second in a deal valued at $297 million.

Key Points: 
  • On July 26, 2021, West Suburban announced that it had entered into an agreement to merge with Old Second in a deal valued at $297 million.
  • Pursuant to the merger agreement, West Suburban stockholders will receive 42.413 shares of Old Second common stock and $271.15 in cash for each share of West Suburban common stock owned.
  • Bragar Eagel & Squire is concerned that West Suburbans board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.
  • Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for West Suburbans stockholders.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Athira, Home Point, Rocket, and Rekor and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, July 22, 2021

On this news, the Companys share price fell $7.09, or approximately 39%, to close at $11.15 per share on June 18, 2021.

Key Points: 
  • On this news, the Companys share price fell $7.09, or approximately 39%, to close at $11.15 per share on June 18, 2021.
  • Kawas allegedly engaged in the manipulation of key data in the research through the manipulation of Western blot images.
  • For more information on the Rekor class action go to: https://bespc.com/cases/REKR
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Frequency, DiDi, and CarLotz and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, July 22, 2021

On this news, Frequencys shares fell $28.30, or 78%, to close at $7.99, thereby damaging investors.

Key Points: 
  • On this news, Frequencys shares fell $28.30, or 78%, to close at $7.99, thereby damaging investors.
  • When the true details entered the market, the lawsuit claims that investors suffered damages.
  • For more information on the DiDi class action go to: https://bespc.com/cases/DIDI
    On March 15, 2021, CarLotz announced its fourth quarter and full year 2020 financial results.
  • For more information on the CarLotz class action go to: https://bespc.com/cases/LOTZ
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Athira, Home Point, Rocket, and Rekor and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, July 15, 2021

On this news, the Companys share price fell $7.09, or approximately 39%, to close at $11.15 per share on June 18, 2021.

Key Points: 
  • On this news, the Companys share price fell $7.09, or approximately 39%, to close at $11.15 per share on June 18, 2021.
  • Kawas allegedly engaged in the manipulation of key data in the research through the manipulation of Western blot images.
  • For more information on the Rekor class action go to: https://bespc.com/cases/REKR
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Athira, Home Point, Rocket, and Rekor and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, July 8, 2021

On this news, the Companys share price fell $7.09, or approximately 39%, to close at $11.15 per share on June 18, 2021.

Key Points: 
  • On this news, the Companys share price fell $7.09, or approximately 39%, to close at $11.15 per share on June 18, 2021.
  • Kawas allegedly engaged in the manipulation of key data in the research through the manipulation of Western blot images.
  • For more information on the Rekor class action go to: https://bespc.com/cases/REKR
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Athira, Home Point, and Rocket and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, July 1, 2021

On this news, the Companys share price fell $7.09, or approximately 39%, to close at $11.15 per share on June 18, 2021.

Key Points: 
  • On this news, the Companys share price fell $7.09, or approximately 39%, to close at $11.15 per share on June 18, 2021.
  • Kawas allegedly engaged in the manipulation of key data in the research through the manipulation of Western blot images.
  • On this news, the price of Rocket Companies Class A common stock fell by nearly 17% to close at $19.01 per share.
  • For more information on the Rocket class action go to: https://bespc.com/cases/RKT
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Peloton, ChemoCentryx, and AcelRx and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, June 17, 2021

Peloton also provides connected fitness subscriptions and access to all live and on demand classes.

Key Points: 
  • Peloton also provides connected fitness subscriptions and access to all live and on demand classes.
  • misbrand Dsuvia within the meaning of the Federal Food, Drug and Cosmetic Act (FD&C Act) and make its distribution violative.
  • For more information on the AcelRx class action go to: https://bespc.com/cases/ACRX
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

AT HOME ALERT: Bragar Eagel & Squire, P.C. Notifies Investors of Merger Proxy Filing and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, June 12, 2021

On May 6, 2021, At Home announced that it had signed an agreement to be acquired by H&F for approximately $2.8 billion.

Key Points: 
  • On May 6, 2021, At Home announced that it had signed an agreement to be acquired by H&F for approximately $2.8 billion.
  • Pursuant to the merger agreement, At Home stockholders will receive $36 in cash for each share of At Home common stock owned.
  • On June 2, 2021, At Home released a Preliminary Proxy Statement recommending that stockholders vote in favor of the proposed merger with H&F.
  • Bragar Eagel & Squire is concerned that At Homes board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.